
Others•Others
Lab Tests
BCR-ABL Kuantitatif p210
Examinations are carried out to detect BCR-ABL p210 fusion using real-time quantitative polymerase chain reaction (QPCR) reactions, because> 95% of p210 fusion is found in CML patients. Imatinib, nilotinib, and dasatinib are BCR-ABL tyrosine kinase inhibitors that are designed to inhibit BCR-ABL activity.
Know Well
Explore This Test, Understand Its Benefits and Purpose
1. To monitor therapy and assess the treatment response of patients with Chronic Myeloid Leukemia (CML)
2. Prognosis indicators
3. Initial Indicators of Non-compliance with Therapy
4. Relapse detection
- 01
None
Preparation
Before Your Visit, Know What to Prepare
Follow these before your visit so your results stay accurate.
Not sure how to prepare?
Ask our team before your visit. We will check it for you.
Not sure how to prepare?
Ask our team before your visit. We will check it for you.
Related for You
Before You Decide, Compare Similar Lab Test
Our call center canHelp you choose the right check-up.
24/7Prodia Assistant
Get instant answers anytime, no waiting for a reply.